<html>
<head>PUBMED IDs for CMT2N</head>
<body bgcolor='#C5F0F2'><h1>CMT2N</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21327736/'>Recent advances in the genetics of hereditary axonal sensory-motor neuropathies type 2.</a> August 6  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21327682/'>Targeting granzyme B to tumor cells using a yoked human chorionic gonadotropin.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21327637/'>Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction.</a> June 18  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22009580/'>A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).</a> April 24  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/25817015/'>Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect.</a> May 30  2015<br></body></html>
